Revenue decreases in 2025 were primarily driven by the accounting treatment of deferred revenue from the 2023 YUTIQ license ...

In this resource, learn how operational obstacles can be addressed and to meet industry demand, Explore how pharmaceutical companies can integrate agile and sustainable practices into their ...

Moby Strategic Execution and Commercial Foundation. Management attributes the early 2025 Zasturi revenue of $15.8 million to a d ...

Supply chain volatility isn’t slowing down. Avetta’s 2026 Trends Report reveals why reactive compliance is no longer enough—and how proactive readiness helps organizations ...

The pharmaceutical service provider Vetter has confirmed its plans to build a state-of-the-art production facility in ...

The regulatory framework around biopharmaceutical manufacturing is exacting and continuously evolving. Companies must meet diverse global requirements while staying agile enough to deliver on ...

New Appointments Reinforce Operational Readiness Across Finance, Regulatory Affairs, and Program Leadership Phio ...

AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.

Hyderabad: Aurobindo Pharma Limited on February 27, 2026 announced the completion of a US FDA inspection at Unit I of its wholly owned subsidiary Eugia Pharma Specialities Ltd. The inspection, ...